“Indian Pharma Expo (IPE) 2019” held on 16th, 17th & 18th July 2019 at Pragati Maidan, New Delhi.

The Indian Pharma Expo 2019 was inaugurated on Tuesday 16th Juy at Pragati Maidan New Delhi by Shri. DC Sahu, Dy Director MSME DI Okhala, New Delhi M/O  Micro, small & Medium Enterprise, Government of India with Dr. Monica Sood Bhatia MD CIMS Medica India & Middle East. With the Indian Pharmaceutical Industry growing leaps and bounds, this event has helped the industry overcome several challenges, by identifying cost-effective production techniques, procurement, logistics, etc. This year too, the IPE was an ideal platform for the companies to witness latest advancements in Manufacturing, Research and Development, Packaging Solutions, Supply Chain Management, Franchising, Distribution and many more domains. In addition, the Expo has provided eminent stakeholders in Pharmaceutical Industry as a chance to generate new business leads and to maximize revenue potential.

The Business Excellence Awards’ in the presence of Chief Guest Shri. P Raghvendra Rao Secretary Ministry of Chemicals and Fertilizers; Government of India along with the Guest of Honor Shri. Vijay Kumar Addl Director MSME – Development Institute, New Delhi felicitated the achievers in the Pharmaceutical Industry in the fields of Research and Development, Active Pharmaceutical Ingredients, Formulations, Manufacturing, Packaging, Distribution, Marketing, Franchising, Outsourcing, Supply chain and Logistic Management, and other Support Services. The Awards has also provided much needed recognition to proactive and innovative approaches to help improve the standards of pharmaceutical delivery. Hence the IPE, has added to the prestige and honor of the Business Excellence Awardees.

Being a global event & total of 8500+ visitors attending also from countries like China, Southeast Asia, Latin America, Middle East & Africa the IPE and Business Excellence Awards, brought together eminent personalities from different sectors of Pharmaceutical, Non-pharmaceutical, and Allied-healthcare industries and provided them with an opportunity to exchange information, products, services, and ideas to help identify new business opportunities. The Industry have gained the most, from this one of a kind event by understanding the latest trends and innovations the market has to offer.

Related Posts

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India